Darren Orton

This inventor holds 8 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Stemsynergy Therapeutics, Inc., University of Miami. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Darren Orton. Retrieved from https://idiyas.com/inventor/darren-orton

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 6)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 2 (Patent Applications = 6)

Average Co-Inventor Count = 1.2

ph-index = 3

Forward Citations = 36(Granted Patents)

Company Filing History:

8 out of 8

Stemsynergy Therapeutics, Inc.

where one patent can have more than one assignee

Years Active: 2014-2026

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12545654 - MYC INHIBITORS AND USES THEREOF (2026-02-10),

2. 12275725 - Inhibitors of the notch transcriptional activation complex and methods for use of the same (2025-04-14),

3. 11834446 - Methods and compositions useful in treating cancer and reducing Wnt mediated effects in a cell (2023-12-05),

4. 11512081 - Methods and compositions useful in treating cancer and reducing WNT mediated effects in a cell (2022-11-29),

5. 10975067 - Methods and compositions useful in treating cancer and reducing Wnt mediated effects in a cell (2021-04-13),

6. 9862714 - Methods and compositions useful in treating cancer and reducing Wnt mediated effects in a cell (2018-01-09),

7. 9416101 - Methods and compositions useful in treating cancer and reducing WNT mediated effects in a cell (2016-08-16),

8. 8901306 - Methods and compositions useful in treating cancer and reducing Wnt mediated effects in a cell (2014-12-02),

Title: The Innovative Contributions of Darren Orton

Introduction

Darren Orton is a prominent inventor based in Nashville, TN, known for his significant contributions to the field of biotechnology. With a total of seven patents to his name, he has made remarkable strides in developing innovative solutions for treating diseases, particularly cancer.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Inhibitors of the Notch transcriptional activation complex and methods for use of the same." This patent discloses inhibitors of the Notch transcriptional activation complex, along with methods for their application in treating or preventing diseases such as cancer. The inhibitors described can include compounds of Formula (I) and pharmaceutically acceptable salts thereof. Another notable patent focuses on "Methods and compositions useful in treating cancer and reducing Wnt mediated effects in a cell." This invention provides novel compounds and pharmaceutical compositions aimed at reducing Wnt-mediated effects and treating cancer.

Career Highlights

Darren Orton has had a distinguished career, working with notable organizations such as Stemsynergy Therapeutics, Inc. and the University of Miami. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to cutting-edge research.

Collaborations

Throughout his career, Darren has collaborated with esteemed colleagues, including Anthony J Capobianco and Mark Spyvee. These partnerships have further enhanced his research and innovation efforts.

Conclusion

Darren Orton's contributions to biotechnology and cancer treatment through his patents and collaborations highlight his role as a leading inventor in the field. His innovative work continues to pave the way for advancements in medical science.

Profile summary based on public USPTO records.